Senate Finance Dives Deeper Into PBM Weeds, Including Brand Over Generic Preferences

 
• By Sarah Karlin-Smith

New draft legislation does not include proposal to force PBMs to cover and put generics and biosimilars on lower cost-sharing tiers than their more expensive branded counterparts.

three-tied cake
The Senate Finance Committee wants PBM justification of brand vs. generic, biosimilar tiering preferences. • Source: Shutterstock

More from Legislation

More from Pink Sheet